nsv5380998
- Organism: Homo sapiens
- Study:nstd102 (Clinical Structural Variants)
- Variant Type:copy number variation
- Method Type:Multiple
- Submitted on:GRCh37
- Variant Calls:2
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:1,529,861
- Description:
See descriptions for individual calls in download files
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 9749 SVs from 115 studies. See in: genome view
Overlapping variant regions from other studies: 9749 SVs from 115 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nsv5380998 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000016.10 | Chr16 | 574,055 | 2,103,915 |
nsv5380998 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000016.9 | Chr16 | 624,055 | 2,153,916 |
Variant Call Information
Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv16867101 | duplication | Multiple | Multiple | EPILEPSY, IDIOPATHIC GENERALIZED; EIG; Epilepsy, idiopathic generalized; HYPERALDOSTERONISM, FAMILIAL, TYPE IV; HALD4; Hyperaldosteronism, familial, type IV; Idiopathic generalized epilepsy | Uncertain significance | ClinVar | RCV001316565.1, VCV001017417.2 |
nssv16867214 | duplication | Multiple | Multiple | Epilepsy; Seizure; Seizure Disorders | Uncertain significance | ClinVar | RCV001344085.1, VCV001017417.2 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nssv16867101 | Remapped | Perfect | NC_000016.10:g.(?_ 574055)_(2103915_? )dup | GRCh38.p12 | First Pass | NC_000016.10 | Chr16 | 574,055 | 2,103,915 |
nssv16867214 | Remapped | Perfect | NC_000016.10:g.(?_ 574055)_(2103915_? )dup | GRCh38.p12 | First Pass | NC_000016.10 | Chr16 | 574,055 | 2,103,915 |
nssv16867101 | Submitted genomic | NC_000016.9:g.(?_6 24055)_(2153916_?) dup | GRCh37 (hg19) | NC_000016.9 | Chr16 | 624,055 | 2,153,916 | ||
nssv16867214 | Submitted genomic | NC_000016.9:g.(?_6 24055)_(2153916_?) dup | GRCh37 (hg19) | NC_000016.9 | Chr16 | 624,055 | 2,153,916 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | HGVS | Type | Allele Origin | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv16867101 | GRCh37: NC_000016.9:g.(?_624055)_(2153916_?)dup | duplication | germline | EPILEPSY, IDIOPATHIC GENERALIZED; EIG; Epilepsy, idiopathic generalized; HYPERALDOSTERONISM, FAMILIAL, TYPE IV; HALD4; Hyperaldosteronism, familial, type IV; Idiopathic generalized epilepsy | Uncertain significance | ClinVar | RCV001316565.1, VCV001017417.2 |
nssv16867214 | GRCh37: NC_000016.9:g.(?_624055)_(2153916_?)dup | duplication | germline | Epilepsy; Seizure; Seizure Disorders | Uncertain significance | ClinVar | RCV001344085.1, VCV001017417.2 |